Publications by authors named "M Opravil"

Claim this Profile
P
Progression of Liver Fibrosis in HIV/HCV Co-Infection: A Comparison between Non-Invasive Assessment Methods and Liver Biopsy.
Patrick Schmid, Andrea Bregenzer, Milo Huber, Andri Rauch, Wolfram Jochum, Milos Opravil

PLoS One· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher CNS penetration-effectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid.
Alexia Cusini, Pietro L Vernazza, Sabine Yerly, Laurent A Decosterd, Bruno Ledergerber, Milos Opravil

J Acquir Immune Defic Syndr· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of once-daily darunavir/ritonavir versus lopinavir/ritonavir on metabolic parameters in treatment-naive HIV-1-infected patients at week 96: ARTEMIS.
E Arathoon, S Schneider, E Baraldi, P L Lim, M Opravil

Int J STD AIDS· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The dose-response relationship of peginterferon alfa-2a and ribavirin in the treatment of patients coinfected with HIV-HCV.
Milos Opravil, Maribel Rodriguez-Torres, Jürgen Rockstroh, Eric Snoeck, Raymond T Chung

HIV Clin Trials· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral-naive HIV-1 patients: the ARTEN Trial.
Vicente Soriano, Keikawus Arastéh, Horacio Migrone, Thomas Lutz, Milos Opravil

Antivir Ther· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis